Welcome!

News Feed Item

Acute Heart Failure Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Acute Heart Failure Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

Acute Heart Failure Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Acute Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Acute Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 6
Acute Heart Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acute Heart Failure 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29

Prominent Sponsors 30
Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Acute Heart Failure 33
Jul 28, 2014: Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Nile Therapeutics, Inc. 35
Clinical Trial Overview of Nile Therapeutics, Inc. 35
Cardiorentis AG 36
Clinical Trial Overview of Cardiorentis AG 36
Amgen Inc. 37
Clinical Trial Overview of Amgen Inc. 37
Abbott Laboratories 38
Clinical Trial Overview of Abbott Laboratories 38
Cytokinetics, Inc. 39
Clinical Trial Overview of Cytokinetics, Inc. 39
Biogen Idec Inc. 40
Clinical Trial Overview of Biogen Idec Inc. 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Alere Inc. 42
Clinical Trial Overview of Alere Inc. 42

Actelion Ltd 43
Clinical Trial Overview of Actelion Ltd 43
Clinical Trial Overview of Top Institutes / Government 44
Duke University 44
Clinical Trial Overview of Duke University 44
National Cerebral and Cardiovascular Center 45
Clinical Trial Overview of National Cerebral and Cardiovascular Center 45
University Hospital Basel 46
Clinical Trial Overview of University Hospital Basel 46
Assistance Publique - Hopitaux de Paris 47
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 47
French Cardiology Society 48
Clinical Trial Overview of French Cardiology Society 48
Northwestern University 49
Clinical Trial Overview of Northwestern University 49
University Hospital of Larissa 50
Clinical Trial Overview of University Hospital of Larissa 50
The Cleveland Clinic 51
Clinical Trial Overview of The Cleveland Clinic 51
Hebei Medical University 52
Clinical Trial Overview of Hebei Medical University 52
YAMAGUCHI UNIVERSITY 53
Clinical Trial Overview of YAMAGUCHI UNIVERSITY 53
Five Key Clinical Profiles 54
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83

List of Tables

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Acute Heart Failure Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Nile Therapeutics, Inc., 2014* 35
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiorentis AG, 2014* 36

Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 37
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 38
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Inc., 2014* 39
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 40
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 41
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alere Inc., 2014* 42
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 43
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 44
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cerebral and Cardiovascular Center, 2014* 45
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 46
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 47
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by French Cardiology Society, 2014* 48
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 49
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Larissa, 2014* 50
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014* 51
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hebei Medical University, 2014* 52
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by YAMAGUCHI UNIVERSITY, 2014* 53

List of Figures

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 82

To order this report: Acute Heart Failure Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Today most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes significant work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reducti...
SYS-CON Events announced today that Interface Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Interface Corporation is a company developing, manufacturing and marketing high quality and wide variety of industrial computers and interface modules such as PCIs and PCI express. For more information, visit http://www.i...
SYS-CON Events announced today that mruby Forum will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. mruby is the lightweight implementation of the Ruby language. We introduce mruby and the mruby IoT framework that enhances development productivity. For more information, visit http://forum.mruby.org/.
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
In his session at @ThingsExpo, Greg Gorman is the Director, IoT Developer Ecosystem, Watson IoT, will provide a short tutorial on Node-RED, a Node.js-based programming tool for wiring together hardware devices, APIs and online services in new and interesting ways. It provides a browser-based editor that makes it easy to wire together flows using a wide range of nodes in the palette that can be deployed to its runtime in a single-click. There is a large library of contributed nodes that help so...
What is the best strategy for selecting the right offshore company for your business? In his session at 21st Cloud Expo, Alan Winters, U.S. Head of Business Development at MobiDev, will discuss the things to look for - positive and negative - in evaluating your options. He will also discuss how to maximize productivity with your offshore developers. Before you start your search, clearly understand your business needs and how that impacts software choices.
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 21st Cloud Expo, Lennart Frantzell, a Developer Advocate with IBM, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing devel...
SYS-CON Events announced today that Cedexis will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Cedexis is the leader in data-driven enterprise global traffic management. Whether optimizing traffic through datacenters, clouds, CDNs, or any combination, Cedexis solutions drive quality and cost-effectiveness.
SYS-CON Events announced today that Mobile Create USA will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Mobile Create USA Inc. is an MVNO-based business model that uses portable communication devices and cellular-based infrastructure in the development, sales, operation and mobile communications systems incorporating GPS capabi...
While some developers care passionately about how data centers and clouds are architected, for most, it is only the end result that matters. To the majority of companies, technology exists to solve a business problem, and only delivers value when it is solving that problem. 2017 brings the mainstream adoption of containers for production workloads. In his session at 21st Cloud Expo, Ben McCormack, VP of Operations at Evernote, will discuss how data centers of the future will be managed, how th...
Why Federal cloud? What is in Federal Clouds and integrations? This session will identify the process and the FedRAMP initiative. But is it sufficient? What is the remedy for keeping abreast of cutting-edge technology? In his session at 21st Cloud Expo, Rasananda Behera will examine the proposed solutions: Private or public or hybrid cloud Responsible governing bodies How can we accomplish?
There is huge complexity in implementing a successful digital business that requires efficient on-premise and cloud back-end infrastructure, IT and Internet of Things (IoT) data, analytics, Machine Learning, Artificial Intelligence (AI) and Digital Applications. In the data center alone, there are physical and virtual infrastructures, multiple operating systems, multiple applications and new and emerging business and technological paradigms such as cloud computing and XaaS. And then there are pe...
SYS-CON Events announced today that MIRAI Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MIRAI Inc. are IT consultants from the public sector whose mission is to solve social issues by technology and innovation and to create a meaningful future for people.
SYS-CON Events announced today that Keisoku Research Consultant Co. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Keisoku Research Consultant, Co. offers research and consulting in a wide range of civil engineering-related fields from information construction to preservation of cultural properties. For more information, vi...
Most of the time there is a lot of work involved to move to the cloud, and most of that isn't really related to AWS or Azure or Google Cloud. Before we talk about public cloud vendors and DevOps tools, there are usually several technical and non-technical challenges that are connected to it and that every company needs to solve to move to the cloud. In his session at 21st Cloud Expo, Stefano Bellasio, CEO and founder of Cloud Academy Inc., will discuss what the tools, disciplines, and cultural...